Study Summary
This trial will test how well a new device prototype works in measuring oxygen and movement.
Eligible Conditions
- Hypoxia
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 1 Secondary · Reporting Duration: 15-20 minutes depending on the patients questions.
15 hours
Comparing Dove device against FDA approved SpO2 sensor
15-20 minutes depending on the patients questions.
Questionnaire about comfort of device
Trial Safety
Safety Progress
Trial Design
0 Treatment Group
40 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 15-20 minutes depending on the patients questions.
Who is running the clinical trial?
University of PennsylvaniaLead Sponsor
1,844 Previous Clinical Trials
41,138,048 Total Patients Enrolled
3 Trials studying Hypoxia
155 Patients Enrolled for Hypoxia
Eligibility Criteria
Age 18+ · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments